Methenamine and sodium salicylate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Overview
Methenamine and sodium salicylate is an analgesic that is FDA approved for the treatment of painful and burning urination. Common adverse reactions include hypersensitivity.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
- Temporarily relieves
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Methenamine and sodium salicylate in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Methenamine and sodium salicylate in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Methenamine and sodium salicylate FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Methenamine and sodium salicylate in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Methenamine and sodium salicylate in pediatric patients.
Contraindications
There is limited information regarding Methenamine and sodium salicylate Contraindications in the drug label.
Warnings
Reye's syndrome
- Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.
- Stomach bleeding warning: This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may cause stomach bleeding. The chance is higher if you age 60 or older have stomach ulcers or bleeding problems
- Take a blood thinner (anticoagulant) or teroid drug
- Take other drugs containing an NSAID (aspirin, ibuprofen, naproxen, or others)
- Have 3 or more alcoholic drinks every day while using this product
- Take more or for a longer time than directed.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Methenamine and sodium salicylate Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Methenamine and sodium salicylate Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Methenamine and sodium salicylate Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Methenamine and sodium salicylate in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Methenamine and sodium salicylate in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Methenamine and sodium salicylate during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Methenamine and sodium salicylate in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Methenamine and sodium salicylate in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Methenamine and sodium salicylate in geriatric settings.
Gender
There is no FDA guidance on the use of Methenamine and sodium salicylate with respect to specific gender populations.
Race
There is no FDA guidance on the use of Methenamine and sodium salicylate with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Methenamine and sodium salicylate in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Methenamine and sodium salicylate in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Methenamine and sodium salicylate in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Methenamine and sodium salicylate in patients who are immunocompromised.
Administration and Monitoring
Administration
Monitoring
There is limited information regarding Methenamine and sodium salicylate Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Methenamine and sodium salicylate and IV administrations.
Overdosage
There is limited information regarding Methenamine and sodium salicylate overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Methenamine and sodium salicylate Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Methenamine and sodium salicylate Mechanism of Action in the drug label.
Structure
There is limited information regarding Methenamine and sodium salicylate Structure in the drug label.
Pharmacodynamics
There is limited information regarding Methenamine and sodium salicylate Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Methenamine and sodium salicylate Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Methenamine and sodium salicylate Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Methenamine and sodium salicylate Clinical Studies in the drug label.
How Supplied
There is limited information regarding Methenamine and sodium salicylate How Supplied in the drug label.
Storage
There is limited information regarding Methenamine and sodium salicylate Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Methenamine and sodium salicylate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Methenamine and sodium salicylate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Methenamine and sodium salicylate Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Methenamine and sodium salicylate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- CYSTEX PLUS ®[1]
Look-Alike Drug Names
There is limited information regarding Methenamine and sodium salicylate Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
{{#subobject:
|Label Page=Methenamine and sodium salicylate |Label Name=M&S 01.jpg
}}
{{#subobject:
|Label Page=Methenamine and sodium salicylate |Label Name=DailyMed - CYSTEX PLUS- methenamine and sodium salicylate tablet .png
}}